Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 5, 2013, Pages 628-633

  El Kady, Nabeel M ^a   Esmat, Gamal ^a   Mahmoud, Ekram H ^a   Darweesh, Samar K ^a   Mahmoud, Sherif H ^a   Elagawy, Waleed A ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL HEPATOLOGY AND TROPICAL MEDICINE RESEARCH INSTITUTE   (Egypt)

Author keywords

chemoembolization; hepatocellular carcinoma; hypertonic saline; local ablation; radiofrequency ablation

Indexed keywords

SODIUM CHLORIDE;

ADULT; ARTICLE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GANGRENE; HEAT LOSS; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; TROPICAL MEDICINE;

CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; CHEMOEMBOLIZATION, THERAPEUTIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SALINE SOLUTION, HYPERTONIC; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84876413163     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835d2c4f     Document Type: Article

References (35)

1. Marelli L, Stigliano R, Triantos C, Senzolo M, Cholongitas E, Davies N, et al. Treatment outcomes for hepatocellular carcinoma using chemoembolization in combination with other therapies. Cancer Treat Rev 2006; 32:594-606. (Pubitemid 44645026)
2. Ng KKC, Poon RTP. Role of radiofrequency ablation for liver malignancies. Surg Pract 2005; 9:94-103.
3. Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000; 217:633-646.
4. Huo T, Huang GYH, Wu JC, Chiang JH, Lee PC, Chang FY, et al. Comparison of transarterial chemoembolization and percutaneous acetic acid injection as the primary locoregional therapy for unresectable hepatocellular carcinoma: a prospective survey. Aliment Pharmacol Ther 2004; 19:1301-1308. (Pubitemid 38859507)
5. Yamakado K, Nakatsuka A, Ohmori SH, Shiraki K, Nakano T, Ikoma J, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol 2002; 13:1225-1232. (Pubitemid 35440314)
6. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radiofrequency ablation of medium and large lesions. Radiology 2000; 214:761-768. (Pubitemid 30115377)
7. Soliman A. Predictive factors of response in the treatment of hepatocellular carcinoma by radiofrequency versus acetic acid injection [MD thesis]. Giza, Egypt: Tropical Medicine, Cairo University; 2003.
8. Elkady N, Abdel Haleem H, Ramzy I, Medhat E. Percutaneous hot saline injection therapy in treatment of hepatocellular carcinoma: a preliminary study. J Egypt Med Assoc 2000; 83 (7-12):149-165.
9. Solbiati L, Ierace T, Tonolini M, Cova L. Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound. Eur J Radiol 2004; 51:S19-S23. (Pubitemid 38845009)
10. Scudamore C. Volumetric radiofrequency ablation: technical considerations. Cancer J 2000; 6 (Suppl 4):s316-s318.
11. Salama H. High intensity focused ultrasound (HIFU), ESTT (Egyptian Society of Thermo-Therapy), Second Annual Congress; Cairo, Egypt, 2003.
12. Ng K, Poon RT, Lo CM, Yuen J, Tso WK, Fan ST. Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma. J Gastrointest Surg 2007; 12:183-191.
13. Neeman Z, Wood BJ. Radiofrequency ablation beyond the liver. Tech Vasc Interv Radiol 2002; 5:156-163. (Pubitemid 36078171)
14. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 2003; 37:429-442. (Pubitemid 36152543)
15. Cheng BQ, Jia CQ, Liu CT, Fan W, Wang QL, Zhang ZL, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm. A randomized controlled trial. JAMA 2008; 299:1669-1677. (Pubitemid 351519864)
16. El-Kady N, Hasan E, Esmat G, Nabeel M, Hamdy S, Foad A, et al. Study of the enhancing effect of sodium chloride injection on radiofrequency ablation of hepatocellular carcinoma. Arab J Gastroenterol 2009; 10:63-67.
17. Omata M, Tateishi R, Yoshida H, Shiina S. Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation. Gastroenterology 2004; 127 (Suppl 1):S159-S166. (Pubitemid 39423384)
18. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210:655-661. (Pubitemid 29124024)
19. Kim TS, Lim HK, Kim H. Excessive hyperthermic necrosis of a pulmonary lobe after hypertonic saline-enhanced monopolar radiofrequency ablation. Cardiovasc Intervent Radiol 2006; 29:160-163. (Pubitemid 43128161)
20. Miao Y, Ni Y, Mulier S, Yu J, De Wever I, Penninckx F, et al. Treatment of VX2 liver tumor in rabbits with 'wet' electrode mediated radio-frequency ablation. Eur Radiol 2000; 10:188-194. (Pubitemid 30141154)
21. Lee JM, Kim YK, Lee YH, Kim SW, Li CA, Kim CS. Percutaneous radiofrequency thermal ablation with hypertonic saline injection: in vivo study in a rabbit liver model. Korean J Radiol 2003; 4:27-34. (Pubitemid 38569483)
22. Munver R, Threatt CB, Delvecchio FC, Preminger GM, Polascik TJ. Hypertonic saline-augmented radiofrequency ablation of VX2 tumor implanted in rabbit kidney: a short-term survival pilot study. Urology 2002; 60:170-175. (Pubitemid 34722980)
23. Burdío F, Güemes A, Burdío JM, Navarro A, Sousa R, Castiella T, et al. Bipolar saline-enhanced electrode for radiofrequency ablation: results of experimental study of in vivo porcine liver. Radiology 2003; 229:447-456. (Pubitemid 37310832)
24. Lee JM, Han JK, Kim SH, Sohn KL, Lee KH, Ah SK, Choi BI. A comparative experimental study of the in-vitro efficiency of hypertonic saline-enhanced hepatic bipolar and monopolar radiofrequency ablation. Korean J Radiol 2003; 4:163-169. (Pubitemid 38569474)
25. Lee JM, Han JK, Kim SH, Lee JY, Choi SH, Choi BI. Hepatic bipolar radiofrequency ablation using perfused-cooled electrodes: a comparative study in the ex vivo bovine liver. Br J Radiol 2004; 77:944-949. (Pubitemid 39600238)
26. Frieser M, Haensler J, Schaber S, Peters A, Mohelsky E, Bernatik T, et al. Radiofrequency ablation of liver tumors: how to enlarge the necrotic zones? Eur Surg Res 2004; 36:357-361. (Pubitemid 39664196)
27. Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, et al. Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors. Zhonghua Yi Xue Za Zhi 2011; 91:1167-1172.
28. Gadaleta C, Catino A, Ranieri G, Fazio V, Gadaleta-Caldarola G, Cramarossa A, et al. Single-step therapy - feasibility and safety of simultaneous transarterial chemoembolization and radiofrequency ablation for hepatic malignancies. In vivo 2009; 23:813-820.
29. Fan WZ, Yang JY, LüMD, Xie XY, Yin XY, Huang YH, et al. Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors. Zhonghua Yi Xue Za Zhi 2011; 91:2190-2194.
30. Chang NK, Shin SS, Kim JW, Kim HJ, Jeong YY, Heo SH, et al. Effect of ultrasound-guided radiofrequency ablation in incompletely treated hepatocellular carcinoma after transcatheter arterial chemoembolization. Korean J Radiol 2012; 13 (Suppl 1):S104-S111, [Epub 23 April 2012].
31. Nabeel MM. Comparative study between percutaneous ethanol injection and radiofrequency thermal ablation in treatment of hepatocellular carcinoma [MSc thesis]. Giza, Egypt: Tropical Medicine, Cairo University; 2003.
32. Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, et al. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments. Cancer 1996; 77:2022-2031. (Pubitemid 26142044)
33. Kagawa T, Koizumi J, Kojima S, Nagata N, Numata M, Watanabe N, et al. Transcatheter arterial chemoembolization plus radiofrequency ablation therapy for early stage hepatocellular carcinoma: comparison with surgical resection. Cancer 2010; 116:3638-3644.
34. Kim JW, Kim JH,Won HJ, Shin YM, Yoon HK, Sung KB, et al. Hepatocellular carcinomas 2-3 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol 2012; 81:e189-e193, [Epub 25 February 2011].
35. Zhao M, Wang JP, Wu PH, Zhang FJ, Huang ZL, Li W, et al. Comparative analysis of TACE alone or plus RFA in the treatment of 167 cases of intermediate and advanced staged primary hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi 2010; 90:2916-2921.